LIAN Insider Trading Activity and SEC Form 4 Filings
LIAN insider trading summary
No open-market insider purchases or sales of LianBio (LIAN) have been reported on SEC Form 4 in the past 12 months.
Latest LIAN insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Jan 2, 2024 | Ehong Gu | Interim CFO | Sell | $8K (1,731 @ $4.34) |
| Jan 3, 2023 | Jiang Qian | SVP, China General Manager | Sell | $4K (2,239 @ $1.65) |
| Aug 18, 2022 | Perceptive Venture Advisors, LLC | Director | Buy | $2.4M (998,240 @ $2.40) |
| Aug 18, 2022 | Perceptive Life Sciences Master Fund Ltd | Director | Buy | $2.4M (998,240 @ $2.40) |
| Aug 18, 2022 | C2 Life Sciences LLC | Director | Buy | $2.4M (998,240 @ $2.40) |
| Aug 18, 2022 | LEV LB Holdings, LP | Director | Buy | $2.4M (998,240 @ $2.40) |
| Aug 18, 2022 | Perceptive Xontogeny Venture Fund, LP | Director | Buy | $2.4M (998,240 @ $2.40) |
| Aug 18, 2022 | LEV LB Holdings GP, LLC | Director | Buy | $2.4M (998,240 @ $2.40) |
| Aug 18, 2022 | Joseph Edelman | Director | Buy | $2.4M (998,240 @ $2.40) |
| Aug 18, 2022 | Perceptive Advisors LLC | Director | Buy | $2.4M (998,240 @ $2.40) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.